# LRRC57

## Overview
The LRRC57 gene encodes the leucine-rich repeat-containing 57 protein, which is part of a family of proteins characterized by the presence of leucine-rich repeat (LRR) motifs. These motifs are typically involved in protein-protein interactions, suggesting that LRRC57 may play a role in cellular signaling or structural organization (Levchenko2023Genomic). Although the precise biological function of the LRRC57 protein remains to be fully elucidated, it is hypothesized to be involved in the regulation of gene transcription, potentially through interactions with expression quantitative trait loci (eQTLs) and cis-regulatory elements (Levchenko2023Genomic). The gene has been associated with bipolar disorder, with studies indicating differential expression patterns in fetal and adult brain tissues, which may contribute to the disorder's pathogenesis (Hall2020Ciseffects; O’Brien2018Expression). Further research is required to understand the full spectrum of LRRC57's biological roles and its implications in human health.

## Clinical Significance
The LRRC57 gene has been implicated in the pathogenesis of bipolar disorder (BD). Studies have identified LRRC57 as a gene associated with BD through various genomic analyses, including transcriptome-wide association studies (TWAS) and summary data-based Mendelian randomization (SMR) (Levchenko2023Genomic). The gene's expression in the fetal brain has been linked to genetic risk for BD, with increased expression associated with the disorder (O’Brien2018Expression). However, the direction of association differs between fetal and adult brain tissues, suggesting complex expression patterns that may influence BD risk (Hall2020Ciseffects).

Despite these associations, the clinical significance of LRRC57 mutations or expression alterations remains unclear. The gene's role in BD is considered less obvious compared to other genes, and its function is not well understood (Levchenko2023Genomic). Research indicates that LRRC57 may be involved in gene transcription regulation through its association with expression quantitative trait loci (eQTLs) and cis-regulatory elements, but specific clinical implications of these interactions have not been detailed (Levchenko2023Genomic). Further studies are needed to clarify the gene's contribution to BD and other potential conditions.


## References


[1. (Hall2020Ciseffects) Lynsey S. Hall, Oliver Pain, Heath E. O’Brien, Richard Anney, James T. R. Walters, Michael J. Owen, Michael C. O’Donovan, and Nicholas J. Bray. Cis-effects on gene expression in the human prenatal brain associated with genetic risk for neuropsychiatric disorders. Molecular Psychiatry, 26(6):2082–2088, May 2020. URL: http://dx.doi.org/10.1038/s41380-020-0743-3, doi:10.1038/s41380-020-0743-3. This article has 23 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-020-0743-3)

[2. (O’Brien2018Expression) Heath E. O’Brien, Eilis Hannon, Matthew J. Hill, Carolina C. Toste, Matthew J. Robertson, Joanne E. Morgan, Gemma McLaughlin, Cathryn M. Lewis, Leonard C. Schalkwyk, Lynsey S. Hall, Antonio F. Pardiñas, Michael J. Owen, Michael C. O’Donovan, Jonathan Mill, and Nicholas J. Bray. Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders. Genome Biology, November 2018. URL: http://dx.doi.org/10.1186/s13059-018-1567-1, doi:10.1186/s13059-018-1567-1. This article has 131 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13059-018-1567-1)

[3. (Levchenko2023Genomic) Anastasia Levchenko and Maria Plotnikova. Genomic regulatory sequences in the pathogenesis of bipolar disorder. Frontiers in Psychiatry, February 2023. URL: http://dx.doi.org/10.3389/fpsyt.2023.1115924, doi:10.3389/fpsyt.2023.1115924. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fpsyt.2023.1115924)